Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Angered – page 18

469 clinical trials in Angered, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Angered at a glance
469
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

469 trials in Angered

Open in trial search

Efficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atumelnant
  • Sponsor:Crinetics Pharmaceuticals Inc.

Erectile dysfunction

Not yet recruiting

Safety and Efficacy of LIB-01 Monohydrate in Healthy Adults and Men with Erectile Dysfunction: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2b Study

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:LIB-01 monohydrate
  • Sponsor:Dicot Pharma AB

Adrenogenital syndrome

Not yet recruiting

Long‑term safety and tolerability of asedebart (AG13909) in patients with congenital adrenal hyperplasia

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AG13909
  • Sponsor:H. Lundbeck A/S

Niemann-Pick disease+1

Not yet recruiting

Long‑term safety and tolerability of oral nizubaglustat in patients with rare lysosomal disorders who have completed a prior study

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Nizubaglustat
  • Sponsor:Azafaros B.V.

Pulmonary hypertension

Not yet recruiting

Phase 3 Trial Evaluating Inhaled Mosliciguat for Safety, Efficacy, and Exercise Capacity in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mosliciguat
  • Sponsor:Pulmovant Inc.

Miglustat oral solution safety and efficacy study in pediatric patients with CLN3 disease

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Miglustat
  • Sponsor:Theranexus

Erectile dysfunction+1

Not yet recruiting

Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tadalafil
  • Sponsor:Karolinska Institutet

Cardiovascular disorder+2

Not yet recruiting

Phase III Study Evaluating Efficacy and Safety of Petrelintide in Participants with Overweight or Obesity and Established Cardiovascular Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:F. Hoffmann-La Roche AG

Appendicitis

Not yet recruiting

Shortened postoperative antibiotic course (3 vs 5 days) in children with acute perforated appendicitis using piperacillin/tazobactam drug combination

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Vastra Gotalandsregionen

Multiple sclerosis

Not yet recruiting

Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Adenocarcinoma pancreas

Not yet recruiting

First‑Line Study of Zoldonrasib (RMC‑9805) Drug Combination vs Gemcitabine/Nab‑Paclitaxel in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Daraxonrasib
  • Sponsor:Revolution Medicines Inc.

Non-small cell lung cancer

Not yet recruiting

Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Oslo University Hospital HF

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Angered

What the registry says about research in the country

01 Diabetic Wound Care Research

Clinical research focusing on advanced treatments for diabetic foot ulcers, comparing the effectiveness of different antimicrobial solutions in wound healing processes.

  • Wound Management
  • Diabetes Complications
  • Antimicrobial Therapy

The studies aim to evaluate and improve healing times for patients with chronic diabetic wounds, potentially revolutionizing current treatment approaches in wound care management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.